Editorial introductions

Current Opinion in Nephrology and Hypertension was launched in 1992. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of nephrology and hypertension is divided into 12 sections that are each reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue. SECTION EDITORS Myles WolfMyles WolfMyles Wolf is Professor of Medicine and Chief of the Division of Nephrology at the Duke University School of Medicine, North Carolina, USA. Dr Wolf received his MD from the State University of New York Downstate in Brooklyn, New York. He completed internal medicine training at the Massachusetts General Hospital, USA, and nephrology training at the Massachusetts General Hospital-Brigham and Women's Hospital program. During fellowship, Dr Wolf obtained a Master of Medical Sciences degree in Clinical and Physiological Investigation from Harvard Medical School, USA. After serving on the Harvard Medical School faculty for 5 years, Dr Wolf moved to the University of Miami, USA, Miller School of Medicine where he spent 5 years, eventually serving as Chief of the Division of Nephrology and Hypertension, Director of the University of Miami Clinical Research Center, and Assistant Dean for Translational and Clinical Research. Subsequently, he spent 3 years at the Northwestern University Feinberg School of Medicine as founding Director of the Center for Translational Metabolism and Health within the Institute for Public Health and Medicine, and as Director of the Department of Medicine's Physician-Scientist Training Program. The focus of Dr Wolf's research is disordered mineral metabolism across the spectrum of chronic kidney disease, including dialysis, kidney transplantation and earlier stages. His research has been published in leading journals including the New England Journal of Medicine, JAMA, the Journal of Clinical Investigation, Circulation, Cell Metabolism, Journal of the American Society of Nephrology, and Kidney International, among others. His primary contributions have been in the area of hormonal regulation of phosphate homeostasis. He has helped to characterize the physiological role of fibroblast growth factor 23 in health and in chronic kidney disease, and the impact of elevated fibroblast growth factor 23 levels on adverse clinical outcomes in patients with kidney disease. Since 2002, Dr Wolf's research has been continuously supported by grants from the American Heart Association, National Kidney Foundation, American Society of Nephrology, and National Institutes of Health. He has been primary research mentor for students, residents, fellows and faculty involved in patient-oriented, epidemiological and basic laboratory research. Several of his trainees are now independent investigators and rising national leaders in academic nephrology. He serves on the editorial boards for the Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, Seminars in Nephrology, and Nature Reviews Nephrology, as an ad hoc reviewer for several other journals, and as Editor of the Mineral Metabolism section of Current Opinion in Nephrology and Hypertension. Dr Wolf has delivered numerous invited lectures on his research nationally and internationally, and he has been the recipient of several teaching, mentoring and research awards. In recognition of his scientific contributions, Dr Wolf was elected to the American Society of Clinical Investigation in 2010, received the 2014 Young Investigator Award from the American Society of Nephrology and Kidney Council of the American Heart Association, and was elected to the Association of American Physicians in 2017. David A. BushinskyDavid A. BushinskyDavid A. Bushinsky, is the John J. Kuiper Distinguished Professor of Medicine and of Pharmacology and Physiology at the University of Rochester School of Medicine, USA. He is Chief of the Nephrology Division at the University of Rochester Medical Center and Associate Chair for Academic Affairs in the Department of Medicine. Dr Bushinsky has published several hundred peer-reviewed articles, invited reviews, chapters and editorials focusing on disorders of divalent ion metabolism. His has developed a strain of rats that exhibit genetic hypercalciuria, the most common metabolic abnormality in humans with nephrolithiasis, and spontaneously form kidney stones. The pathophysiology of the hypercalciuria closely parallels that of man and is thus a useful model to study stone formation in humans. He has also extensively studied the mechanism by which metabolic acids induce physicochemical bone dissolution and cell-mediated bone resorption. His research has been consistently funded by grants from the National Institutes of Health for 3 decades. Dr Bushinsky has lectured throughout the world on stone formation, effects of acid on bone and other disorders of divalent ion metabolism. Dr Bushinsky received his medical degree from Tufts University School of Medicine in Boston, Mass., USA. He completed an internship and residency at Tufts New England Medical Center Hospital in Boston, Mass., USA. He also completed a fellowship in clinical nephrology and a research fellowship in nephrology at Tufts New England Medical Center Hospital in Boston, Mass. Dr Bushinsky is a member of a number of organizations including the Association of American Physicians and the American Society for Clinical Investigation. Orson W. MoeOrson W. MoeOrson W. Moe received his medical degree from the University of Toronto, Canada and is currently Professor of Internal Medicine and Physiology at the University of Texas Southwestern Medical Center, Dallas, TX, USA. He is the Director of the Charles and Jane Pak Center of Mineral Metabolism and Clinical Research and Chief of the Division of Nephrology. He is an active clinician and researcher holding the Charles and Jane Pak Distinguished Chair in Mineral Metabolism Research and the Donald Seldin Professorship in Clinical Investigation. Moe conducts both basic science and patient-oriented research on renal physiology and metabolism, and epithelial biology. His research strives to cross from the level of the whole patient, to animal and cell culture models, and down to single molecules. He is active in teaching at the undergraduate and post-graduate level nationally and internationally. In addition to editing Current Opinion in Nephrologyand Hypertension, Moe also serves on the editorial board of the American Journal of Physiology, the Journal of American Society of Nephrology and edits the textbook, The Kidney: Physiology and Pathophysiology by Seldin and Giebisch. Moe is currently a member of the American Society of Clinical Research, American Association of Physicians, American Society of Nephrology, and American Physiologic Society. Susan QuagginSusan QuagginSusan Quaggin graduated from the Faculty of Medicine at the University of Toronto, Canada, in 1988 and received her specialty degree in internal medicine in 1992. She completed her sub-specialty training in nephrology in 1993 at University of Toronto and did a post-doctoral fellowship at Yale University, USA, where she studied the genetic basis of kidney development. Dr Quaggin has served as an elected councillor of the American Society for Clinical Investigation (ASCI), is a member of the Executive Council of the ISN and was elected to the American Association of Physicians (AAP) in 2013. In addition, Dr Quaggin sits on the editorial boards of several journals, is the Deputy Editor of the Journal of the American Society of Nephrology and has organized a number of international renal and vascular meetings. In January 2013, Dr Quaggin joined Northwestern University Feinberg School of Medicine, USA, as the Charles Horace Mayo Professor of Medicine, where she serves as the Director of the Feinberg Cardiovascular Research Institute (FCVRI) and Chief of the Division of Nephrology. Dr Quaggin's research program focuses on genetic pathways required to establish and maintain the integrity of microvascular beds including the glomerular filtration barrier – a highly selective filter that separates the blood from the urinary space. To understand the pathways and interactions between perivascular cells and the endothelium, her research team has developed a number of genetic models that permit cell and time-specific manipulation of gene expression.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.